$INO Up to date company activities and other impor
Post# of 145149
Posted On: 02/20/2014 10:16:46 AM
$INO Up to date company activities and other important information about $INO
$INO
DD Notes ~ http://www.ddnotesmaker.com/INO
##### recent news/filings ~ source: finance.yahoo.com
Wed, 19 Feb 2014 21:14:54 GMT ~ The REAL Inovio Pharmaceuticals: An Interview With Dr. J. Joseph Kim, CEO
read full: http://seekingalpha.com/article/2032351-the-r...urce=yahoo
*********************************************************
Wed, 19 Feb 2014 09:00:00 GMT ~ Inovio Pharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference
- BLUE BELL, Pa., Feb. 19, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that President and CEO, Dr. J. Joseph Kim, will present a corporate overview of the company at the Cowen and Company 34th Annual Health Care Conference in Boston, MA. This webcast will also be available on the homepage of Inovio's website under the webcast tab at www.inovio.com. Inovio is revolutionizing vaccines to prevent and treat today's cancers and challenging infectious diseases.
read full: http://finance.yahoo.com/news/inovio-pharmace...00448.html
*********************************************************
Tue, 18 Feb 2014 19:31:56 GMT ~ 3 Biotech Stocks with Great Upside: Inovio Pharmaceuticals, Dynavax, and Ariad
read full: http://www.fool.com/investing/general/2014/02...lnk0000001
*********************************************************
Tue, 18 Feb 2014 09:00:00 GMT ~ Inovio Pharmaceuticals Bolsters Research and Clinical Development Leadership as it Advances Cancer & Infectious Disease Immunotherapies
- BLUE BELL, Pa., Feb. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has expanded its senior management team with two appointments to help advance the company's growing pipeline of preclinical and clinical DNA vaccines. Inovio has appointed Dr. Laurent Humeau as Vice President of R&D and Dr. Jan Marie-Albert Van Tornout as Vice President of Clinical Development. Prior to Inovio, Dr. Humeau was Senior Director of Translational Research, Human Therapeutics Division for Intrexon and previously Chief Scientific Officer at VIRxSYS Corporation. At Inovio, Dr. Humeau will provide the technical and strategic leadership for its R&D group including: preclinical development of immunotherapy and vaccine candidates, immunology and immune monitoring approaches, method development, product characterization, and analytical development.
read full: http://finance.yahoo.com/news/inovio-pharmace...00879.html
*********************************************************
Mon, 17 Feb 2014 20:34:02 GMT ~ Big Pharma Continues the Race for Electroporation
read full: http://wallstcheatsheet.com/business/big-phar...ml/?ref=YF
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=INO&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=INO&a...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/INO/company-info
Ticker: $INO
OTC Market Place: Not Available
CIK code: 0001055726
Company name: Inovio Pharmaceuticals, Inc.
Company website: http://www.inovio.com/
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/INO/filings
Latest financials: http://www.otcmarkets.com/stock/INO/financials
Latest news: http://www.otcmarkets.com/stock/INO/news - http://finance.yahoo.com/q/h?s=INO+Headlines
Major holdings: http://data.cnbc.com/quotes/INO/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=INO+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/INO.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=INO
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Inovio+Pharmaceuti...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...als%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.inovio.com/
Alexa: http://www.alexa.com/siteinfo/http://www.inovio.com/#
Corporate website internet archive: http://web.archive.org/web/*/http://www.inovio.com/
http://www.pennystocktweets.com/stocks/profile/INO
##### last known share structure ~ source: otcmarkets.com
Market Value: $441,758,114 a/o Feb 19, 2014
Shares Outstanding: 208,376,469 a/o Nov 04, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/INO
$INO
DD Notes ~ http://www.ddnotesmaker.com/INO
##### recent news/filings ~ source: finance.yahoo.com
Wed, 19 Feb 2014 21:14:54 GMT ~ The REAL Inovio Pharmaceuticals: An Interview With Dr. J. Joseph Kim, CEO
read full: http://seekingalpha.com/article/2032351-the-r...urce=yahoo
*********************************************************
Wed, 19 Feb 2014 09:00:00 GMT ~ Inovio Pharmaceuticals to Present at Cowen and Company 34th Annual Health Care Conference
- BLUE BELL, Pa., Feb. 19, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) announced today that President and CEO, Dr. J. Joseph Kim, will present a corporate overview of the company at the Cowen and Company 34th Annual Health Care Conference in Boston, MA. This webcast will also be available on the homepage of Inovio's website under the webcast tab at www.inovio.com. Inovio is revolutionizing vaccines to prevent and treat today's cancers and challenging infectious diseases.
read full: http://finance.yahoo.com/news/inovio-pharmace...00448.html
*********************************************************
Tue, 18 Feb 2014 19:31:56 GMT ~ 3 Biotech Stocks with Great Upside: Inovio Pharmaceuticals, Dynavax, and Ariad
read full: http://www.fool.com/investing/general/2014/02...lnk0000001
*********************************************************
Tue, 18 Feb 2014 09:00:00 GMT ~ Inovio Pharmaceuticals Bolsters Research and Clinical Development Leadership as it Advances Cancer & Infectious Disease Immunotherapies
- BLUE BELL, Pa., Feb. 18, 2014 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has expanded its senior management team with two appointments to help advance the company's growing pipeline of preclinical and clinical DNA vaccines. Inovio has appointed Dr. Laurent Humeau as Vice President of R&D and Dr. Jan Marie-Albert Van Tornout as Vice President of Clinical Development. Prior to Inovio, Dr. Humeau was Senior Director of Translational Research, Human Therapeutics Division for Intrexon and previously Chief Scientific Officer at VIRxSYS Corporation. At Inovio, Dr. Humeau will provide the technical and strategic leadership for its R&D group including: preclinical development of immunotherapy and vaccine candidates, immunology and immune monitoring approaches, method development, product characterization, and analytical development.
read full: http://finance.yahoo.com/news/inovio-pharmace...00879.html
*********************************************************
Mon, 17 Feb 2014 20:34:02 GMT ~ Big Pharma Continues the Race for Electroporation
read full: http://wallstcheatsheet.com/business/big-phar...ml/?ref=YF
*********************************************************
##### chart ~ source: stockcharts.com
stockcharts.com/c-sc/sc?s=INO&p=D&b=5&g=0&id=p95448242713
##### chart ~ source: eoddata.com
http://chart.eoddata.com/?e=OTCBB&s=INO&a...D&b=BB
##### company info ~ source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/INO/company-info
Ticker: $INO
OTC Market Place: Not Available
CIK code: 0001055726
Company name: Inovio Pharmaceuticals, Inc.
Company website: http://www.inovio.com/
Incorporated In: DE, USA
##### extra dd links
Edgar filings: http://www.sec.gov/cgi-bin/browse-edgar?actio...p;count=40
Latest filings: http://www.otcmarkets.com/stock/INO/filings
Latest financials: http://www.otcmarkets.com/stock/INO/financials
Latest news: http://www.otcmarkets.com/stock/INO/news - http://finance.yahoo.com/q/h?s=INO+Headlines
Major holdings: http://data.cnbc.com/quotes/INO/tab/8.1
Insider transactions (1): http://finance.yahoo.com/q/it?s=INO+Insider+Transactions
Insider transactions (2): http://www.secform4.com/insider-trading/INO.htm
Insider transactions (3): http://www.insidercow.com/history/company.jsp?company=INO
RegSho: http://www.regsho.com/tools/symbol_stats.php?...rch=search
DTCC: http://search2.dtcc.com/?q=Inovio+Pharmaceuti...ISO-8859-1
Spoke company information: http://www.spoke.com/search?utf8=%E2%9C%93&am...als%2C+Inc.
Corporation WIKI: http://www.corporationwiki.com/search/results...=0&y=0
WHOIS: http://whois.domaintools.com/http://www.inovio.com/
Alexa: http://www.alexa.com/siteinfo/http://www.inovio.com/#
Corporate website internet archive: http://web.archive.org/web/*/http://www.inovio.com/
http://www.pennystocktweets.com/stocks/profile/INO
##### last known share structure ~ source: otcmarkets.com
Market Value: $441,758,114 a/o Feb 19, 2014
Shares Outstanding: 208,376,469 a/o Nov 04, 2013
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
##### business description ~ source: otcmarkets.com
IC
DD Notes ~ http://www.ddnotesmaker.com/INO
(0)
(0)